GE Healthcare to open biotechnology manufacturing center in the UK

GE Healthcare announced the opening of a biotechnology manufacturing center at the Stevenage Bioscience Catalyst (SBC) Open Innovation Campus, in Stevenage, U.K. In the first half of 2019, the center will start producing a fiber-based purification platform, which has the potential to significantly improve efficiency in the purification steps of manufacturing biopharmaceuticals, gene therapies and viral vectors.
The fiber-based purification platform comprises a material with a unique proprietary structure. This has the potential to significantly improve process speed, flexibility, and robustness during purification, a key step in the manufacturing of biopharmaceuticals. Additional products will also be produced at the center to serve both laboratory and clinical applications.